Efficacy of Ruxolitinib as Inducer of Fetal Hemoglobin in Primary Erythroid Cultures from Sickle Cell and Beta-Thalassemia Patients
Abstract
Share and Cite
Pecoraro, A.; Troia, A.; Maggio, A.; Di Marzo, R. Efficacy of Ruxolitinib as Inducer of Fetal Hemoglobin in Primary Erythroid Cultures from Sickle Cell and Beta-Thalassemia Patients. Thalass. Rep. 2019, 9, 8101. https://doi.org/10.4081/thal.2019.8101
Pecoraro A, Troia A, Maggio A, Di Marzo R. Efficacy of Ruxolitinib as Inducer of Fetal Hemoglobin in Primary Erythroid Cultures from Sickle Cell and Beta-Thalassemia Patients. Thalassemia Reports. 2019; 9(1):8101. https://doi.org/10.4081/thal.2019.8101
Chicago/Turabian StylePecoraro, Alice, Antonio Troia, Aurelio Maggio, and Rosalba Di Marzo. 2019. "Efficacy of Ruxolitinib as Inducer of Fetal Hemoglobin in Primary Erythroid Cultures from Sickle Cell and Beta-Thalassemia Patients" Thalassemia Reports 9, no. 1: 8101. https://doi.org/10.4081/thal.2019.8101